Patients received ingenol mebutate or vehicle for self-application to a 25-cm ( 2 ) contiguous area : 0.015 % once daily for 3 consecutive days ( face/scalp ) or 0.05 % once daily for 2 consecutive days ( trunk/extremities ) .